Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy

NCT06907641 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Post Prostatectomy)

Interventions

DRUG: 64Cu-SAR-bisPSMA

Sponsor

St Vincent's Hospital, Sydney

Collaborators

[object Object]